CRISPR Therapeutics wins new Overweight rating at J.P. Morgan on pipeline prospects CRISPR Therapeutics wins new Overweight rating at J.P. Morgan on pipeline prospects Post Contentcrsp, vrtxRead More You might also be interested in reading Bill Ackman steps down from Universal Music Board. September 18, 2025 In Mainstream ← Previous post Next post →